Results for tag: "Tesamorelin"

Tesamorelin is a synthetic form of growth hormone-releasing hormone (GHRH) used to treat endocrine and metabolic disorders. It is used to reduce excess abdominal fat in HIV-infected patients with lipodystrophy, a condition that causes fat to accumulate in the abdomen and other parts of the body. Tesamorelin is also used to treat growth hormone deficiency in adults. It works by stimulating the body to produce more growth hormone, which helps to reduce fat and improve muscle mass. Tesamorelin is available in the form of an injection and is administered once daily. It is typically prescribed for a period of six months, after which the patient is re-evaluated to determine if further treatment is necessary. The Tesamorelin market is a growing segment of the endocrine and metabolic disorders drugs market. It is a relatively new drug, but has been gaining popularity due to its effectiveness in treating lipodystrophy and growth hormone deficiency. Some companies in the Tesamorelin market include EMD Serono, Inc., Novo Nordisk, and Pfizer, Inc. Show Less Read more